Portfolio

PMK Ventures

Logo for NeuroTerapia with a stylized human head outline, a brain illustration, and a red to blue gradient dotted line beneath the name.

NeuroTherapia (USA)

CNS Diseases and Neuroinflammation (small molecule therapies to treat central nervous system diseases)

Investors:

CRU/PMK Ventures, Better World, Alzheimers Association, Brain Trust Accelerator Fund, and Cleveland Clinic Ventures (exit expected in 2026-2027)

Mitochon Pharmaceuticals logo with a DNA strand illustration, featuring the text 'Mitochon Pharmaceuticals' in blue and gray

Mitochon Pharmaceuticals (USA)

Disease Modifying Therapies For Aging And Neurodegenerative Diseases (small molecule)

Investors:

PMK Ventures, BenFranklin Technology Partnbers (BFTP), Cures Within Reach, YT Angels

Kompanion Care logo with a stylized map icon and purple background.

KompanionCare (France)

Early Detection of Cancer Cachexia (providing first-in- class disruptive imaging product for cancer patients)

Investors:

PMK Ventures, STRT Holding, Interactive Ventures, EPFL Innovation

Logo of VRG Therapeutics, featuring stylized purple dots arranged in a pattern with the company name in purple text.

VRG145 (Hungary)

Noveloraltreatment For Migraine Prophylaxis

Investors:

PMK Venture (lead), Vascular Group, Botanic Bio Holding, Szechenyi

Inno Screen logo featuring a cross symbol with circuit lines and the company name in blue text.

InnoScreen (Singapore)

Early Detection Platform based on digital biomarkers: melanoma, cardiovascular disease, kidney failure and neurodegenerative diseases.

Investors:

PMK Ventures, NKFIH

Brain Health Ltd. (Europe and Asia)

Neurology and Longevity Clinic Franchise, started in central Europe with rapid expansion in entire Europe, Singapore, China, South Korea and Japan.

Investors:

PMK Venture, Business Angels

Under negotiation and Due Diligence process:

Singaporean Biotech Firm with a very promising product for Pain management. Investors: PMK Venture, Singaporean PE Fund

Under negotiation and Due Diligence process:

Hungarian Biotech Firm (University Start-up) with a very promising product for chemotherapy efficacy monitoring.

Investors:

PMK Venture, European VCs, Angel Investors

CR-Ventures

Logo of Astrocyte Pharma featuring a stylized blue astrocyte cell and the text 'astrocyte pharma' in blue.

Astrocyte Pharmaceuticals, Inc. (USA)

Traumatic Brain Injury, Stroke,and Concussion (drug helping recovery and well-being of brain injury patients)

Investors:

CR-Ventures, Kaitai Capital, University of Texas Horizon Fund, Boston Harbor Angels, Mass Medical Angels, SideCar Angels

Bioversys logo with stylized checkmark and company name in blue and gray text.

BioVersys AG (Switzerland)

EXIT: Swiss IPO (SIX) on 07 Feb 2025

Multi-drug resistant bacterial infections

Investors:

CR-Ventures, Innosuisse, AMR Action Fund, European Investment Bank, GSK, CARB-X, Business Angels Switzerland (BAS)

Xeno Biosciences logo with a stylized DNA helix and the company name in gray and purple text.

Xeno Biosciences Inc. (USA)

Obesity and Related Diseases(biotech providing novel class of treatments for metabolic diseases)

Investors:

CR-Ventures, Boston Harbor Angels, Maine Angels, Bangor Angels, Dirigo Angels, Santa Barbara Angels, Beacon Angels, SideCar Angels, NOLA Angel Network, Keirestu, Zhi Gao Holdings

Logo of Adiposs with a red spiral symbol and the company name in black text.

Adiposs SA (Switzerland)

Early Detection of Cancer Cachexia (providing first-in- class disruptive imaging product for cancer patients)

Investors:

CR-Ventures, Privilège Ventures, Kick Foundation, FONGIT, Kingbridge